Alnylam Pharmaceuticals, Inc.Alnylam Pharmaceuticals, Inc.Alnylam Pharmaceuticals, Inc.

Alnylam Pharmaceuticals, Inc.

No trades
See on Supercharts
Market capitalization
‪18.38 B‬USD
−3.53USD
‪−440.24 M‬USD
‪1.83 B‬USD
‪125.76 M‬
Beta (1Y)
1.35

About Alnylam Pharmaceuticals, Inc.

CEO
Yvonne L. Greenstreet
Headquarters
Cambridge
Employees (FY)
‪2.1 K‬
Founded
2002
ISIN
US02043Q1076
FIGI
BBG000BFGNJ5
Alnylam Pharmaceuticals, Inc. is a biopharmaceutical company. It engages in the business of developing and commercializing novel therapeutics based on ribonucleic acid interference. The company was founded by Noble Laureate, David Bartel, Thomas Tuschl, Phillip Zamore, Paul R. Schimmel, and Phillip Allen Sharp on June 14, 2002 and is headquartered in Cambridge, MA.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Curated watchlists where ALNY is featured.

Frequently Asked Questions

The current price of ALNY is 145.16 USD — it has decreased by 0.11% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Alnylam Pharmaceuticals, Inc. stocks are traded under the ticker ALNY.
Alnylam Pharmaceuticals, Inc. is going to release the next earnings report on Apr 25, 2024. Keep track of upcoming events with our Earnings Calendar.
ALNY stock is 1.55% volatile and has beta coefficient of 1.35. Check out the list of the most volatile stocks — is Alnylam Pharmaceuticals, Inc. there?
One year price forecast for Alnylam Pharmaceuticals, Inc. has a max estimate of 395.00 USD and a min estimate of 136.00 USD.
ALNY earnings for the last quarter are 1.15 USD whereas the estimation was −1.45 USD which accounts for 179.55% surprise. Estimated earnings for the next quarter are −1.19 USD. See more details about Alnylam Pharmaceuticals, Inc. earnings.
Alnylam Pharmaceuticals, Inc. revenue for the last quarter amounts to ‪750.53 M‬ USD despite the estimated figure of ‪396.76 M‬ USD. In the next quarter revenue is expected to reach ‪436.92 M‬ USD.
Yes, you can track Alnylam Pharmaceuticals, Inc. financials in yearly and quarterly reports right on TradingView.
ALNY stock has fallen by 5.75% compared to the previous week, the month change is a 1.20% fall, over the last year Alnylam Pharmaceuticals, Inc. has showed a 27.86% decrease.
ALNY net income for the last quarter is ‪−137.87 M‬ USD, while the quarter before that showed ‪147.75 M‬ USD of net income which accounts for −193.31% change. Track more Alnylam Pharmaceuticals, Inc. financial stats to get the full picture.
Today Alnylam Pharmaceuticals, Inc. has the market capitalization of ‪18.38 B‬, it has increased by 3.31% over the last week.
No, ALNY doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, ALNY shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Alnylam Pharmaceuticals, Inc. stock right from TradingView charts — choose your broker and connect to your account.
ALNY reached its all-time high on Dec 21, 2022 with the price of 242.97 USD, and its all-time low was 3.65 USD and was reached on Aug 18, 2004.
See other stocks reaching their highest and lowest prices.
As of Apr 18, 2024, the company has ‪2.10 K‬ employees. See our rating of the largest employees — is Alnylam Pharmaceuticals, Inc. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Alnylam Pharmaceuticals, Inc. technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Alnylam Pharmaceuticals, Inc. stock shows the sell signal. See more of Alnylam Pharmaceuticals, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on Alnylam Pharmaceuticals, Inc. future price: according to them, ALNY price has a max estimate of 395.00 USD and a min estimate of 136.00 USD. Read a more detailed Alnylam Pharmaceuticals, Inc. forecast: see what analysts think of Alnylam Pharmaceuticals, Inc. and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Alnylam Pharmaceuticals, Inc. EBITDA is ‪−228.12 M‬ USD, and current EBITDA margin is −12.48%. See more stats in Alnylam Pharmaceuticals, Inc. financial statements.